NCT04739761 A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04737382 Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. Status RECRUITING Phase NA
NCT04734275 Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04731142 Type 2 Diabetes Exemplar: A Remote Care Service for North West London Status COMPLETED Phase NA
NCT04728230 Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04727528 Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease Status TERMINATED Phase PHASE3
NCT04724837 Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial) Status COMPLETED Phase PHASE2
NCT04723394 Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults Status COMPLETED Phase PHASE3
NCT04722172 A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04716946 Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04716075 Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) Status COMPLETED Phase PHASE2
NCT04712903 Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT04712396 A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body Status COMPLETED Phase PHASE1
NCT04711824 Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT04711252 A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04705727 Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation Status TERMINATED Phase PHASE3
NCT04704934 Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) Status ACTIVE_NOT_RECRUITING Phase PHASE3